7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 
      
    		                     
      cash flows from operating activities:
    		                     
      cash collections from financial royalty assets
    		882,358,000 726,525,000 829,737,000 777,477,000 791,609,000 669,375,000 744,949,000 747,356,000 707,663,000 594,756,000 1,151,635,000 663,337,000 662,545,000 559,665,000 621,689,000 582,707,000 639,053,000 520,148,000 573,946,000 572,712,000 545,707,000 
      cash collections from intangible royalty assets
    		264,000 240,000 177,000 227,000 390,000 486,000 13,544,000 235,000 250,000 200,000 617,000 537,000 1,029,000 35,695,000 35,682,000 38,025,000 37,933,000 39,439,000 35,761,000 39,622,000 34,485,000 
      other royalty cash collections
    		29,107,000 24,051,000 31,759,000 29,512,000 29,811,000 23,212,000 26,311,000 74,568,000 24,722,000 39,868,000 19,685,000 18,284,000 18,891,000 15,371,000 17,345,000 16,654,000 13,381,000 7,267,000 6,821,000 5,691,000 4,066,000 
      distributions from equity method investees
    		0 0 13,396,000 0 0 0 13,396,000 0 313,000 2,243,000 16,267,000 5,826,000 5,814,000 6,812,000 20,690,000       
      interest received
    		7,248,000 8,662,000 12,025,000 9,035,000 16,533,000 14,484,000 6,430,000 8,469,000 28,622,000 18,945,000 15,568,000 14,426,000 7,294,000 2,780,000 482,000 131,000 672,000 784,000 1,548,000 228,000 3,879,000 
      development-stage funding payments
    		-50,500,000 -300,500,000 -50,500,000                   
      payments for operating and professional costs
    		-34,175,000 -94,025,000 -101,696,000 -72,421,000 -55,232,000 -48,051,000 -60,521,000 -54,173,000 -54,961,000 -47,032,000 -86,846,000 -81,316,000 -48,650,000 -44,101,000 -48,902,000 -49,239,000 -53,508,000 -39,604,000 -42,160,000 -50,327,000 -59,397,000 
      payments for employee epas
    		-1,695,000                     
      interest paid
    		-129,992,000 -796,000 -138,822,000 -805,000 -78,997,000 -797,000 -78,971,000 -3,327,000 -82,589,000 -663,000 -82,589,000 -663,000 -82,596,000 -664,000 -86,216,000 -671,000 -65,259,000 0 -64,500,000 -767,000 -18,998,000 
      net cash from operating activities
    		702,615,000 363,984,000 596,076,000 742,525,000 703,614,000 658,209,000 664,638,000 772,628,000 573,520,000 607,817,000 1,033,837,000 569,931,000 538,827,000 574,952,000 460,270,000 489,957,000 469,759,000 531,720,000 526,100,000 565,673,000 508,848,000 
      cash flows from investing activities:
    		                     
      acquisition of businesses, net of cash acquired
    		-226,000                     
      investments in equity method investees
    		   0 0 -3,984,000 -6,971,000 -1,992,000 -3,984,000 -2,987,000 -3,579,000 0 -6,846,000 0 -3,050,000       
      purchases of equity securities
    		0 0 -4,427,000 0 -12,500,000       -25,000,000 0 -28,785,000 -34,000,000 -35,121,000      
      proceeds from equity securities
    		   0 0       165,000,000    0 6,590,000     
      purchases of available for sale debt securities
    		0   0 0       -85,822,000 -314,579,000 -14,579,000 -64,579,000 -17,686,000 -17,585,000 -17,585,000 -17,585,000   
      proceeds from available for sale debt securities
    		2,880,000 2,880,000 12,586,000 12,586,000 2,880,000 2,880,000 1,440,000     495,169,000 15,625,000 15,625,000 15,625,000 15,625,000 15,625,000 15,625,000 15,625,000   
      proceeds from sales of available for sale debt securities
    		0 0 510,553,000                   
      acquisitions of financial royalty assets
    		-961,873,000 -1,114,000 -1,057,000 -496,418,000 -1,194,571,000 -728,628,000 -86,084,000 -1,002,239,000 -451,132,000 -60,446,000 -601,705,000 -250,241,000 -1,316,306,000 -175,008,000 -85,000 -171,734,000 -1,336,027,000 -180,671,000 -503,070,000 -805,161,000 -802,465,000 
      acquisitions of other financial assets
    		   0 0       0 0         
      milestone payments
    		0 -218,600,000 -50,000,000 -25,000,000 0   0 0 0 -12,400,000     0 0     
      other
    		0   0 1,000                 
      net cash from investing activities
    		   -505,588,000 -1,192,701,000 -893,176,000 -86,650,000 -1,000,172,000 -450,658,000   414,742,000 -1,425,150,000   -551,646,000 -845,500,000 126,166,000 -599,300,000  -1,004,602,000 
      cash flows from financing activities:
    		                     
      distributions to legacy non-controlling interests - portfolio receipts
    		-101,907,000 -89,220,000 -84,625,000 -81,202,000 -101,555,000 -91,915,000 -87,608,000               
      distributions to continuing non-controlling interests
    		-34,281,000 -38,605,000 -53,833,000 -31,448,000 -31,018,000 -30,682,000 -32,011,000 -24,489,000 -31,122,000 -30,529,000 -33,394,000           
      dividends to shareholders
    		-95,312,000 -93,241,000 -95,357,000 -93,656,000 -94,061,000 -94,943,000 -93,805,000 -89,338,000 -89,751,000 -90,605,000 -88,633,000 -84,201,000 -83,809,000 -83,049,000 -82,263,000 -73,603,000 -73,017,000 -72,581,000 -65,983,000 -57,605,000  
      repurchases of class a ordinary shares
    		-146,493,000 -291,572,000 -708,781,000 -52,607,000 -97,045,000   -30,200,000 -140,117,000             
      contributions from legacy non-controlling interests - r&d
    		-219,000 219,000 220,000 220,000 219,000 220,000 88,000 88,000 88,000 88,000 279,000           
      contributions from non-controlling interests - other
    		15,000 4,605,000 1,077,000 1,031,000 1,041,000 950,000 1,338,000 1,018,000 1,657,000 945,000 3,313,000           
      proceeds from revolving credit facility
    		                     
      repayment of revolving credit facility
    		                     
      repayment of long-term debt
    		       0              
      proceeds from issuance of long-term debt, net of discount
    		   0 0                 
      debt issuance costs and other
    		   -300,000 -3,088,000           -801,000    -151,000 -37,745,000 
      net cash (used in)/provided by financing activities
    		562,735,000           -265,550,000      -224,415,000 -226,670,000   
      net change in cash and cash equivalents
    		307,036,000 -455,812,000 158,694,000 -21,026,000 -814,592,000 921,644,000 365,990,000 -459,438,000 -1,236,629,000 197,388,000 264,938,000 719,123,000 -1,116,409,000 316,520,000 250,469,000 -259,760,000 658,527,000 433,471,000 -299,870,000 -544,122,000 -853,145,000 
      cash and cash equivalents, beginning of period
    		0 0 929,026,000 0 0 0 477,010,000 0 0 0 1,710,751,000  0 0 1,541,048,000  0 0 1,008,680,000  -37,483,000 
      cash and cash equivalents, end of period
    		307,036,000 -455,812,000 1,087,720,000 -21,026,000 -814,592,000 921,644,000 843,000,000 -459,438,000 -1,236,629,000 197,388,000 1,975,689,000  -1,116,409,000 316,520,000 1,791,517,000  658,527,000 433,471,000 708,810,000  -890,628,000 
      net cash provided by/(used in) investing activities
    		 -311,982,000 503,917,000            11,165,000       
      net cash from financing activities
    		  -941,299,000    -211,998,000  -1,359,491,000 -346,996,000 -210,373,000   -228,254,000 -220,966,000       
      development-stage funding payments - ongoing
    		   -500,000 -500,000 -500,000 -500,000 -500,000 -500,000 -500,000 -500,000 -500,000 -500,000 -606,000 -500,000      -5,095,000 
      development-stage funding payments - upfront and milestone
    		       0    -50,000,000 -25,000,000         
      purchases of marketable securities
    		           0 0 -57,515,000 -177,354,000 -440,911,000 -27,643,000 -222,686,000 -505,339,000   
      proceeds from sales and maturities of marketable securities
    		       0 0 0 24,391,000 115,636,000 150,798,000 251,299,000 274,608,000 104,716,000 624,446,000 448,906,000 419,783,000 205,836,000 255,887,000 
      distributions to legacy non-controlling interests - other
    		                     
      cash acquired in connection with purchase of non-controlling interest
    		                     
      net cash provided by/(used in) in financing activities
    		                     
      net cash provided by/(used in) financing activities
    		    -325,505,000               -277,393,000 -357,391,000 
      derivative collateral received
    		               0 23,190,000     
      derivative collateral posted
    		               0 -25,320,000     
      termination payments on derivative instruments
    		               0      
      net (cash used in)/provided by in financing activities
    		                     
      distributions to legacy non-controlling interests - royalty receipts
    		        -100,246,000 -92,453,000 -91,938,000           
      net cash (used in)/provided by investing activities
    		          -558,526,000           
      distributions to shareholders/unitholders
    		                   0 2,000 
      scheduled repayments of long-term debt
    		                   0 0 
      repayments of long-term debt
    		                   0 -5,945,800,000 
      proceeds from issuance of class a ordinary shares upon ipo, net of offering costs
    		                   -907,000  
      cash and cash equivalents, beginning of year
    		                     
      cash and cash equivalents, end of year
    		                     
      distributions to non-controlling interests
    		            -107,183,000 -109,158,000 -106,385,000       
      distributions to non-controlling interests- other
    		            -40,956,000 -37,828,000 -34,515,000       
      contributions from non-controlling interests- r&d
    		            240,000 107,000 624,000       
      contributions from non-controlling interests- other
    		            1,622,000 1,674,000 1,573,000       
      development-stage funding payments - upfront and milestones
    		              -100,000,000       
      distributions from non-consolidated affiliates
    		               6,171,000 6,210,000 4,678,000 17,325,000 6,293,000 4,201,000 
      ongoing development-stage funding payments
    		               -613,000 -500,000 -3,122,000 -2,641,000   
      upfront development-stage funding payments
    		               -103,208,000      
      investments in non-consolidated affiliates
    		               -6,535,000 -10,893,000 -8,713,000 -8,714,000 -10,893,000 0 
      purchase of warrants
    		                     
      distributions to non-controlling interest
    		               -115,980,000 -125,427,000 -112,476,000 -125,721,000 -143,059,000 -116,347,000 
      distributions to non-controlling interest- other
    		               -34,293,000 -32,529,000 -49,795,000 -37,183,000 -106,904,000 -46,176,000 
      contributions from non-controlling interest- r&d
    		               1,256,000 2,003,000 2,083,000 1,997,000 2,261,000 1,107,000 
      contributions from non-controlling interest- other
    		               25,350,000 2,950,000 8,354,000 220,000 28,972,000 17,360,000 
      purchase of treasury interests
    		                     
      proceeds from issuance of long-term debt
    		                   0 5,851,030,000 
      swap collateral received
    		                   0 0 
      swap termination payments
    		                   0 0 
      swap collateral posted
    		                     
      payments for rebates
    		                     
      purchase of equity securities
    		                    0 
      purchase of marketable securities
    		                    -458,024,000 
      contributions from non-controlling interest- acquisitions
    		                     
      proceeds from issuance of ordinary shares upon initial public offering, net of offering costs
    		                     
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.